Liothyronine Sodium
NDC 75907-039, Liothyronine Sodium, tablet, from Dr. Reddy's Labratories Inc..
- Product NDC
- 75907-039
- Status
- Listed
- Labeler
- Dr. Reddy's Labratories Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090097
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75907-039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM5 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75907-039-01 | 75907003901 | 100 TABLET in 1 BOTTLE, PLASTIC (75907-039-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0b0f2db9-642d-d84f-b102-b43de34bbe75NADAC price for package 75907003901
GET /v1/drugs/nadac/75907003901
Use it
Look up 75907-039 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75907-039 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75907-039. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.